A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

NCT02716116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: TAK-788

Sponsor

Takeda